Dihydromyricetin affect the pharmacokinetics of triptolide in rats
Sign Up to like & getrecommendations! Published in 2019 at "Xenobiotica"
DOI: 10.1080/00498254.2019.1616851
Abstract: Abstract 1. Dihydromyricetin (DMY) has anti-tumor and hepatoprotective activities and inhibits the activity of CYP enzymes and P-gp. In this research, we explored the effect of DMY on the pharmacokinetics of triptolide (TP), an anti-tumor… read more here.
Keywords: medicine; dihydromyricetin affect; affect pharmacokinetics; triptolide rats ... See more keywords